NCT00940160View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

January 31, 2010

Conditions
Asthma
Interventions
DRUG

QAX576

DRUG

QAX576

DRUG

QAX576

DRUG

Placebo

Trial Locations (3)

Unknown

Novartis Investigator Site, Moscow

Novartis Investigator Site, Saint Petersburg

Novartis Investigator Site, Manchester

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY